Morgan Stanley
OXGN

Morgan Stanley’s OXIGENE INC COM OXGN Stock Holding History

Morgan Stanley’s Portfolio OXGN Stock Details OXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,350
Closed -$11K – 7032
2016
Q1 		$11K Hold
13,350
– – ﹤0.01% 6123
2015
Q4 		$10K Sell
13,350
-2,254
-14% -$1.99K ﹤0.01% 6256
2015
Q3 		$15K Sell
15,604
-48
-0.3% -$63 ﹤0.01% 6150
2015
Q2 		$21K Sell
15,652
-2,042
-12% -$3K ﹤0.01% 6133
2015
Q1 		$25K Sell
17,694
-61,508
-78% -$102K ﹤0.01% 5999
2014
Q4 		$128K Buy
79,202
+67,388
+570% +$130K ﹤0.01% 5447
2014
Q3 		$25K Sell
11,814
-4,668
-28% -$10.8K ﹤0.01% 5945
2014
Q2 		$43K Sell
16,482
-8,034
-33% -$23.4K ﹤0.01% 5818
2014
Q1 		$91K Buy
+24,516
New +$68.1K ﹤0.01% 5491

Morgan Stanley's OXGN Position: Q2 2016 in Review

Morgan Stanley sold out of OXIGENE INC COM (OXGN) in Q2 2016, closing a stake of 13,350 shares — an estimated $11K sold.

Morgan Stanley first reported a position in OXGN in Q1 2014 and held it in 9 quarters. The position peaked at $128K in Q4 2014. 0 funds tracked by Wall St. Rank hold OXGN as of Q2 2016.

  • Morgan Stanley reported no remaining OXIGENE INC COM position as of Q2 2016 after selling out during the quarter.
  • Morgan Stanley sold 13,350 OXIGENE INC COM shares in Q2 2016, an estimated $11K.
  • Morgan Stanley first reported a position in OXIGENE INC COM in Q1 2014 and held it in 9 quarters.
  • Morgan Stanley's OXIGENE INC COM position peaked at $128K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held OXIGENE INC COM as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.